News archive
Showing 680 results
September 2012
-
Media Release
Novartis Pharmaceuticals Corporation emprende una campaña de educación de la comunidad hispana de EE. UU. sobre la enfermedad de Alzheimer
La iniciativa busca ayudar a cerrar la brecha del diagnóstico de los hispanos a través de recursos e información en español sobre la enfermedad de Alzheimer La compañía trabajará junto a Univision… -
Media Release
Novartis Pharmaceuticals Corporation embarks on Alzheimer’s disease educational effort for the U.S. Hispanic community
The initiative aims to help close diagnosis gap for Hispanic Americans by providing in-language information and resources focused on Alzheimer’s diseaseThe company will work with Univision to help… -
Media Release
Novartis Pharmaceuticals Corporation emprende una campaña de educación de la comunidad hispana de EE. UU. sobre la enfermedad de Alzheimer
-
Media Release
Novartis Pharmaceuticals Corporation embarks on Alzheimer’s disease educational effort for the U.S. Hispanic community
-
Media Release
FDA Advisory Committee supports use of tobramycin inhalation powder from Novartis for patients with cystic fibrosis
-Tobramycin inhalation powder (TIP) recommended for management of cystic fibrosis (CF) patients six years and older with P. aeruginosa bacteria in their lungs-P. aeruginosa (Pa) is the leading cause… -
Media Release
FDA Advisory Committee supports use of tobramycin inhalation powder from Novartis for patients with cystic fibrosis
-
Media Release
Higher dose of Novartis drug Exelon® Patch approved by FDA for patients with mild to moderate Alzheimer's disease
-- Approval based on efficacy and safety demonstrated in long-term study comparing 13.3 mg/24 h to 9.5 mg/24 h in declining mild to moderate Alzheimer's patients-- New higher dose of Exelon Patch… -
Media Release
Higher dose of Novartis drug Exelon® Patch approved by FDA for patients with mild to moderate Alzheimer's disease
June 2012
-
Media Release
NPC Statement on Comments Made in Media Coverage of Paycheck Fairness Act
Novartis Pharmaceuticals Corporation (NPC) is aware of the recent Democratic Steering and Policy Committee session in the U.S. House of Representatives to discuss the Paycheck Fairness Act and… -
Media Release
NPC Statement on Comments Made in Media Coverage of Paycheck Fairness Act